Abstract
0183 Progranulin (PC-derived growth factor) levels in serum do not predict response to neoadjuvant capecitabine (X), docetaxel (T) and trastuzumab (H) for patients (pts) with locally advanced breast cancer (LABC)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have